Johnson & Johnson ordered to pay $55 million in talc-powder trial
NEW YORK (Reuters) - Johnson & Johnson was ordered by a U.S. jury on Monday to pay $55 million to a woman who said that using the company’s talc-powder products for feminine hygiene caused her to develop ovarian cancer.
No comments:
Post a Comment